Johnson & Johnson offers $8.9 billion to settle talc 'cancer' claims
This is an increase of $6.9 billion over the $2 billion previously committed by Johnson & Johnson.
johnson johnson
April 2023
November 2021
September 2018
Vaccine cos, scientists in war mode to tame Omicron coronavirus
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
Regulator asks J&J to pay Rs 20 lakh for each faulty hip implant
Government sets up experts’ panel to determine compensation amount.
